Question 1

Who are the top researchers at Lentigen Technology (United States)?

Accepted Answer

Ranked on the quality score, Rimas J. Orentas, Dina Schneider and Boro Dropulić lead among researchers whose main affiliation is Lentigen Technology (United States).

Question 2

What are the most cited papers from Lentigen Technology (United States)?

Accepted Answer

The most cited paper from Lentigen Technology (United States) is "CD22-targeted CAR T cells induce remission in B-ALL that is naive or resistant to CD19-targeted CAR immunotherapy" (Terry J. Fry et al., 2017), with 1,367 citations. Next come "Bispecific anti-CD20, anti-CD19 CAR T cells for relapsed B cell malignancies: a phase 1 dose escalation and expansion trial" (469) and "A tandem CD19/CD20 CAR lentiviral vector drives on-target and off-target antigen modulation in leukemia cell lines" (265).

Question 3

Which research topics does Lentigen Technology (United States) publish most on?

Accepted Answer

By volume in 2022-now: CAR-T cell therapy research, Viral Infectious Diseases and Gene Expression in Insects, Immune Cell Function and Interaction and Virus-based gene therapy research.

Question 4

Which keywords describe research at Lentigen Technology (United States)?

Accepted Answer

By fractional works in 2022-now, weighted toward what it does more of than the world: Cancer Immunotherapy, Lymphoma, Immunotherapy, CAR T Cells, Chimeric Antigen Receptor, Glycosylation, Monoclonal Antibodies and Mammalian Cells.

Question 5

Which fields of science does Lentigen Technology (United States) work in?

Accepted Answer

In 2022-now, 58% of research at Lentigen Technology (United States) is in Health Sciences, 35% in Life Sciences. Its largest fields are Medicine (58%), Immunology and Microbiology (18%), Biochemistry, Genetics and Molecular Biology (16%). It does 2.1× the world's share of Health Sciences.

Question 6

Is Lentigen Technology (United States)'s research output growing?

Accepted Answer

Output in 2022-2025 was 3% higher than in 2018-2021.